Orchestra BioMed Holdings, Inc. OBIO
NASDAQ · United States · Health Technology
$5.95-0.40 (-6.30%)
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2026-08-10 | -0.38 | -0.39 | +3.1% | $88.00K | -36.1% | +3.8%$4.24→$4.40 |
| Q1 2026 | 2026-05-12 | -0.33 | -0.40 | +17.5% | — | — | +3.8%$3.91→$4.06 |
| Q4 2025 | 2026-03-12 | 0.26 | -0.38 | +168.4% | — | — | -8.7%$4.60→$4.20 |
| Q3 2025 | 2025-11-10 | -0.40 | -0.38 | -5.3% | — | — | +7.6%$3.81→$4.10 |
| Q4 2024 | 2025-03-31 | -0.43 | -0.42 | -2.4% | — | — | — |
| Q2 2024 | 2024-08-12 | -0.45 | -0.40 | -12.5% | — | — | — |
| Q1 2024 | 2024-05-13 | -0.38 | -0.38 | 0.0% | — | — | — |
| Q4 2023 | 2024-03-27 | -0.32 | -0.34 | +5.9% | — | — | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.